The Health Service Products (Provision and Disclosure of Information) Regulations 2018

Meaning of “special health service medicine”, “imported special health service medicine”, “made special health service medicine” and listing of a presentation of special health service medicine in a Drug Tariff

This section has no associated Explanatory Memorandum

10.—(1) In these Regulations

“imported special health service medicine” means a special health service medicine which is imported into the United Kingdom;

“made special health service medicine” means a special health service medicine which is manufactured in the United Kingdom;

“special health service medicine” means a health service medicine which is a special medicinal product (within the meaning of regulation 167(1) of the 2012 Regulations).

(2) For the purposes of this Part, a presentation of special health service medicine is listed in a Drug Tariff if a price for that presentation is listed—

(a)in the Drug Tariff (England) for the given month,

(b)in the Drug Tariff (Wales) for the given month,

(c)in the Drug Tariff (Scotland) for the given month, or

(d)in the Drug Tariff (Northern Ireland) for the given month.

(3) For the purposes of determining whether a reimbursement price is listed for a presentation, any pack size specified in the relevant Drug Tariff is to be disregarded.

(1)

Regulation 167 of the 2012 Regulations was amended by S.I. 2017/715.